Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

Follow-On Contribution and Restructuring

29 Aug 2019 07:00

RNS Number : 4662K
Duke Royalty Limited
29 August 2019
 

29 August 2019

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

Follow-On Contribution and Restructuring with Existing Royalty Partner

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce a follow-on investment of £0.25 million and restructuring of its Royalty Partner, Pearl & Dean Cinemas Limited ("the Pearl & Dean Group").

Duke has restructured its investment, which now totals £2.75 million, by moving the entire Royalty Agreement from the Pearl & Dean Group, a UK and Irish cinema advertising business, to its parent company, Step Investments Limited ("SIL").

SIL is a diversified investment vehicle with interests in several profitable and cash-generative UK and Irish businesses, spanning the media and hospitality & leisure sectors. The restructuring will therefore provide Duke with exposure across the broader SIL portfolio, increasing the security of the investment.

Highlights: 

·; The Pearl and Dean Group is the sixth Royalty Partner to receive a follow-on investment by Duke and the second Partner secured through the Capital Step acquisition

·; Investment terms remain as a perpetual royalty, with a pro-forma cash yield of approximately 18.0% on total invested capital and potential for further revenue participation depending on future growth

·; SIL will use the follow-on investment to add a new Dublin-based luxury restaurant and entertainment venue, Hyde, to its portfolio

·; Pearl & Dean Group has successfully completed a fundraise recently to restructure its debt and to fund future growth

·; The new investments into the Pearl & Dean Group and Hyde are expected to accelerate growth of these operating companies to which Duke's revenue participation is tied

·; Restructuring of this Royalty Partner increases security of Duke's investment

 

Royalty Partner - SIL: 

SIL's investments are focused on the media and hospitality and leisure sectors, both of which are areas of focus for Duke.  

SIL retains a majority stake in the Pearl & Dean Group, comprising the UK cinema advertiser Pearl & Dean ("P&D") and Irish sister company Wide Eye Media ("WEM"). P&D was founded in 1953 and works with a wide range of cinemas, including independent operators and large multiplex chains across the UK. WEM (formerly Carlton Screen Advertising) was founded in 1996 and has 100% market share of the Irish cinema advertising industry. SIL also owns minority stakes in other profitable Irish media businesses.

In addition to media, SIL also has several investments in the restaurant industry in Ireland, a sector which the directors believe also lends itself favourably to the royalty industry. SIL is currently in the process of developing a luxury restaurant and entertainment venue called Hyde in central Dublin, Ireland, to add to its hospitality portfolio.

About the Financing:

As a result of its latest contribution, Duke's new exposure to SIL amounts to £2.75 million, with a pro-forma cash yield of approximately 18.0%, at the floor. As previously announced, the investment is structured as a perpetual royalty, with the return calculated as a fixed percentage of gross revenues, subject to a floor and a cap of 30%. The commercial terms of the agreement remain the same, namely that only Hyde and the Pearl & Dean Group are included in the gross revenue calculation.

SIL will use the additional funds from Duke principally to fit-out the Hyde restaurant and entertainment venue in central Dublin, delivering a new revenue stream to SIL.  The Pearl & Dean Group has also recently successfully raised funds, through a combination of debt and equity, to fuel future growth and to refinance its existing debt. The Pearl & Dean Group fundraise was led by The Firmament Group, a US-based provider of tailored debt and equity capital solutions to small and medium-sized enterprises.

The additional revenue anticipated from both growth initiatives are anticipated to have a positive impact on the future royalty receipts received by Duke from SIL as gross revenue grows above the floor calculation. The restructuring gives Duke the senior position in the SIL capital structure, which includes first-ranking security over several profitable businesses within SIL, as well as security over fixed assets outside it.  

Finally, as part of this follow-on investment, Duke has secured the right, but not the obligation, to provide additional future investment into SIL as and when new growth/expansion opportunities arise.

Neil Johnson, CEO of Duke Royalty, said:

"This investment benefits all parties concerned and reinforces Duke's reputation as a flexible and long-term funding partner for business in the UK, Europe and abroad. For Duke and its shareholders, this restructuring means that our royalty receipts are poised to benefit from multiple growth opportunities as SIL launches its new venue, Hyde, alongside the range of planned initiatives from the Pearl & Dean Group thanks to the new funds raised through The Firmament Group. This deal also enhances the value of our overall security on the investment."

Duke Royalty Portfolio

Following this follow-on investment into SIL, Duke's portfolio of core royalty investments is as follows:

 

Royalty Partner

Total Investment Amount

Date of Initial Investment

Temarca B.V.

€10,700,000

April 2017

Berkley Recruitment (Group) Limited

€1,300,000

June 2017

Welltel (Ireland) Limited

€6,900,000

June 2017

Lynx Equity (UK) Limited

£10,000,000

October 2017

Xtremepush Limited

£2,000,000

February 2018

Trimite Global Coatings Limited

£10,000,000

March 2018

United Glass Group Ltd (formerly Brownhills Investments Limited)

£7,500,000

April 2018

Step Investments Limited

£2,750,000

June 2018

BHPC Limited

€4,600,000

August 2018

InterHealth Canada

£10,000,000

August 2018

Brightwater Selection (Ireland) Limited

€1,875,000

September 2018

MRDB Holdings Limited Group

£10,000,000

February 2019

 

***ENDS***

 

About Duke

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

+44 (0) 1481 741 240

Cenkos Securities plc

(Nominated Adviser and Broker)

Stephen Keys / Callum Davidson (Nomad) / Julian Morse / Michael Johnson (Brokers)

+44 (0) 207 397 8900

Newgate Communications

(PR)

Elisabeth Cowell / Ian Silvera / Megan Kovach

+44 (0) 20 3757 6880

Dukeroyalty@newgatecomms.com

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUWVVRKKAWUAR
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.